This post may contain affiliate links which may compensate us based on your interaction. Please read the disclosures for more information.
See the state Medicaid programs that cover medication to treat obesity — and how much they spend.
The growing popularity of GLP-1 receptor agonists — drugs that include Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound from Eli Lilly — has added fuel to an already fiery debate over the government’s role in subsidizing access to these drugs. Originally developed for Type 2 diabetes, these medications have proven highly effective for treating obesity — a chronic condition…
More from my site
Make No Mistake, the IRS Wants Their Cut Of Your Winnings
Here’s What Happens When You Invest $100 a Month for 40 Years
Changing Insurance Companies Can Be a Hassle. Here’s Why You May Want to Do It Anyway
Here’s What Happens When You Invest All Your Money in Crypto
Have You Set Up a Pet Profile on Amazon? Here’s Why You Should
The 5 Most Valuable Hotel Rewards Programs to Join
